Drug information for NEVIRAPINE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
SUSPENSION; ORAL 50MG/5ML Tentative Approval   NEVIRAPINE Nevirapine AUROBINDO PHARMA LTD 77702
2006-01-06 Letter
TABLET, FOR SUSPENSION; ORAL 100MG Tentative Approval   NEVIRAPINE Nevirapine CIPLA LIMITED 202212
2012-05-03 Letter
TABLET, FOR SUSPENSION; ORAL 50MG Tentative Approval   NEVIRAPINE Nevirapine CIPLA LIMITED   "
TABLET; ORAL 200MG Tentative Approval   NEVIRAPINE Nevirapine MYLAN PHARMS INC 202523
TABLET; ORAL 200MG Tentative Approval   NEVIRAPINE Nevirapine SCIEGEN PHARM INC. 203176
2012-05-03 Letter
TABLET; ORAL 200MG Tentative Approval   NEVIRAPINE Nevirapine RANBAXY 77429
2005-06-21 Letter
TABLET; ORAL 200MG Tentative Approval   NEVIRAPINE Nevirapine AUROBINDO 77521
2005-06-21 Letter
TABLET; ORAL 200MG Tentative Approval   NEVIRAPINE Nevirapine CIPLA LIMITED 77956
2006-05-21 Letter
TABLET; ORAL 200MG Tentative Approval   NEVIRAPINE Nevirapine STRIDES ACROLAB 78195
2006-08-18 Letter
TABLET; ORAL 200MG Tentative Approval   NEVIRAPINE Nevirapine HETERO DRUGS 78584
2007-08-14 Letter
TABLET; ORAL 200MG Tentative Approval   NEVIRAPINE Nevirapine HUAHAI US INC. 78644
2007-07-16 Letter
TABLET; ORAL 200MG Tentative Approval   NEVIRAPINE Nevirapine MATRIX LABS 78864
2008-05-21 Letter
TABLET; ORAL 200MG Tentative Approval   NEVIRAPINE Nevirapine EMCURE PHARMA 78887
2007-10-04 Letter
TABLET; ORAL 200MG Tentative Approval   NEVIRAPINE Nevirapine MACLEODS PHARMA 90688
2009-04-03 Letter

Drug Adverse Effects information for NEVIRAPINE

Role code Indications Reaction # Reports
PS ACQUIRED IMMUNODEFICIENCY SYNDROME ABORTION SPONTANEOUS 1
PS ACQUIRED IMMUNODEFICIENCY SYNDROME MATERNAL DRUGS AFFECTING FOETUS 1
PS BASEDOW'S DISEASE DRUG INTERACTION 2
PS BASEDOW'S DISEASE HYPOTHYROIDISM 2
PS DRUG LEVEL DEHYDRATION 1
PS DRUG LEVEL DIARRHOEA 1
PS HIV INFECTION ABSCESS NECK 3
PS HIV INFECTION ANAEMIA 4
PS HIV INFECTION ASCITES 4
PS HIV INFECTION CHOLESTASIS 3
PS HIV INFECTION CHRONIC HEPATITIS 4
PS HIV INFECTION CREATININE RENAL CLEARANCE DECREASED 8
PS HIV INFECTION DEHYDRATION 2
PS HIV INFECTION DIARRHOEA 2
PS HIV INFECTION DRUG INTERACTION 12
PS HIV INFECTION HEPATIC ENZYME INCREASED 4
PS HIV INFECTION HEPATITIS ACUTE 3
PS HIV INFECTION HYPOTHYROIDISM 12
PS HIV INFECTION IMMUNE RECONSTITUTION SYNDROME 3
PS HIV INFECTION JAUNDICE 3
PS HIV INFECTION KLEBSIELLA INFECTION 3
PS HIV INFECTION LARGE INTESTINAL HAEMORRHAGE 4
PS HIV INFECTION LYMPHADENITIS BACTERIAL 3
PS HIV INFECTION MALARIA 2
PS HIV INFECTION MATERNAL EXPOSURE DURING PREGNANCY 4
PS HIV INFECTION MELAENA 4
PS HIV INFECTION MENINGITIS CRYPTOCOCCAL 1
PS HIV INFECTION PORTAL HYPERTENSION 4
PS HIV INFECTION PREGNANCY 4
PS HIV INFECTION TUBERCULOSIS 2
PS HIV INFECTION VARICES OESOPHAGEAL 4
PS HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION MENINGITIS CRYPTOCOCCAL 1
PS MATERNAL EXPOSURE DURING PREGNANCY FOETAL DISTRESS SYNDROME 3
PS PROPHYLAXIS MENINGITIS CRYPTOCOCCAL 1
PS THYROID CYST DRUG INTERACTION 2
PS THYROID CYST HYPOTHYROIDISM 2
SS ACQUIRED IMMUNODEFICIENCY SYNDROME CARDIAC VENTRICULAR DISORDER 2
SS ACQUIRED IMMUNODEFICIENCY SYNDROME MATERNAL DRUGS AFFECTING FOETUS 4
SS ACQUIRED IMMUNODEFICIENCY SYNDROME VENTRICULAR SEPTAL DEFECT 4
SS ADJUSTMENT DISORDER SUICIDE ATTEMPT 2
SS ANTIRETROVIRAL THERAPY CACHEXIA 8
SS ANTIRETROVIRAL THERAPY CHRONIC FATIGUE SYNDROME 8
SS ANTIRETROVIRAL THERAPY COUGH 3
SS ANTIRETROVIRAL THERAPY DEPRESSION 8
SS ANTIRETROVIRAL THERAPY DEVELOPMENTAL DELAY 3
SS ANTIRETROVIRAL THERAPY DYSPNOEA 3
SS ANTIRETROVIRAL THERAPY FACIAL WASTING 8
SS ANTIRETROVIRAL THERAPY FOETAL EXPOSURE DURING PREGNANCY 6
SS ANTIRETROVIRAL THERAPY GLUCOSE TOLERANCE IMPAIRED 6
SS ANTIRETROVIRAL THERAPY HEPATOMEGALY 3
SS ANTIRETROVIRAL THERAPY HEPATOSPLENOMEGALY 3
SS ANTIRETROVIRAL THERAPY HIGH DENSITY LIPOPROTEIN DECREASED 6
SS ANTIRETROVIRAL THERAPY HYPERTRIGLYCERIDAEMIA 6
SS ANTIRETROVIRAL THERAPY HYPOAESTHESIA 8
SS ANTIRETROVIRAL THERAPY LACTIC ACIDOSIS 6
SS ANTIRETROVIRAL THERAPY LIPOATROPHY 6
SS ANTIRETROVIRAL THERAPY LIPODYSTROPHY ACQUIRED 8
SS ANTIRETROVIRAL THERAPY LYMPHADENITIS 3
SS ANTIRETROVIRAL THERAPY LYMPHADENOPATHY 3
SS ANTIRETROVIRAL THERAPY MUSCLE SPASTICITY 3
SS ANTIRETROVIRAL THERAPY PYREXIA 3
SS ANTIRETROVIRAL THERAPY RENAL FAILURE ACUTE 3
SS ANTIRETROVIRAL THERAPY VASODILATATION 8
SS ANTIVIRAL TREATMENT ABORTION SPONTANEOUS 2
SS ANTIVIRAL TREATMENT MATERNAL EXPOSURE DURING PREGNANCY 2
SS BACK PAIN SUICIDAL IDEATION 2
SS BACK PAIN SUICIDE ATTEMPT 3
SS DYSPEPSIA SUICIDAL IDEATION 2
SS DYSPEPSIA SUICIDE ATTEMPT 3
SS HEAD DISCOMFORT SUICIDAL IDEATION 2
SS HEAD DISCOMFORT SUICIDE ATTEMPT 3
SS HIV INFECTION ABSCESS NECK 3
SS HIV INFECTION ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 10
SS HIV INFECTION ANAEMIA 3
SS HIV INFECTION ANAPHYLACTIC SHOCK 10
SS HIV INFECTION ASTHENIA 10
SS HIV INFECTION BLOOD THYROID STIMULATING HORMONE INCREASED 2
SS HIV INFECTION CASTLEMAN'S DISEASE 10
SS HIV INFECTION CD4 LYMPHOCYTES INCREASED 17
SS HIV INFECTION CEREBRAL TOXOPLASMOSIS 17
SS HIV INFECTION CREATININE RENAL CLEARANCE DECREASED 8
SS HIV INFECTION DIABETES MELLITUS 2
SS HIV INFECTION DIARRHOEA 17
SS HIV INFECTION DRUG INTERACTION 2
SS HIV INFECTION DRUG RESISTANCE 27
SS HIV INFECTION EAR INFECTION 17
SS HIV INFECTION EPILEPSY 17
SS HIV INFECTION FOETAL EXPOSURE DURING PREGNANCY 6
SS HIV INFECTION GASTROINTESTINAL DISORDER 17
SS HIV INFECTION GENERALISED ERYTHEMA 10
SS HIV INFECTION HEPATOTOXICITY 17
SS HIV INFECTION HERPES SIMPLEX 3
SS HIV INFECTION IMMUNE RECONSTITUTION SYNDROME 23
SS HIV INFECTION KLEBSIELLA INFECTION 3
SS HIV INFECTION LIPOATROPHY 3
SS HIV INFECTION LYMPHADENITIS BACTERIAL 3
SS HIV INFECTION MALARIA 2
SS HIV INFECTION MATERNAL EXPOSURE DURING PREGNANCY 4
SS HIV INFECTION MENINGITIS 17
SS HIV INFECTION MENINGITIS CRYPTOCOCCAL 2
SS HIV INFECTION MONOPLEGIA 17
SS HIV INFECTION MUSCLE ATROPHY 3
SS HIV INFECTION NAUSEA 17
SS HIV INFECTION OESOPHAGEAL CANDIDIASIS 17
SS HIV INFECTION PANCYTOPENIA 10
SS HIV INFECTION PNEUMONIA STREPTOCOCCAL 17
SS HIV INFECTION POLYNEUROPATHY 17
SS HIV INFECTION PORTAL HYPERTENSION 44
SS HIV INFECTION PREMATURE BABY 8
SS HIV INFECTION QUADRIPARESIS 17
SS HIV INFECTION SCROTAL ULCER 3
SS HIV INFECTION SEPSIS 17
SS HIV INFECTION SUICIDAL IDEATION 4
SS HIV INFECTION SUICIDE ATTEMPT 6
SS HIV INFECTION TREATMENT FAILURE 17
SS HIV INFECTION TREATMENT NONCOMPLIANCE 17
SS HIV INFECTION TUBERCULOSIS 2
SS HIV INFECTION VENTRICULAR SEPTAL DEFECT 10
SS HIV INFECTION VIITH NERVE PARALYSIS 17
SS HIV INFECTION VIRAL LOAD INCREASED 17
SS HIV INFECTION VOMITING 17
SS HIV INFECTION WEIGHT DECREASED 10
SS HIV INFECTION WEIGHT INCREASED 3
SS HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION MENINGITIS CRYPTOCOCCAL 2
SS MATERNAL EXPOSURE DURING PREGNANCY MATERNAL EXPOSURE DURING PREGNANCY 8
SS MATERNAL EXPOSURE DURING PREGNANCY PREMATURE BABY 4
SS MATERNAL EXPOSURE DURING PREGNANCY VENTRICULAR SEPTAL DEFECT 8
SS MATERNAL EXPOSURE TIMING UNSPECIFIED FOETAL EXPOSURE DURING PREGNANCY 8
SS MATERNAL EXPOSURE TIMING UNSPECIFIED PREMATURE BABY 8
SS MATERNAL EXPOSURE TIMING UNSPECIFIED VENTRICULAR SEPTAL DEFECT 8
SS PARAESTHESIA SUICIDAL IDEATION 2
SS PARAESTHESIA SUICIDE ATTEMPT 3
SS PNEUMONIA STREPTOCOCCAL CD4 LYMPHOCYTES INCREASED 1
SS PNEUMONIA STREPTOCOCCAL CEREBRAL TOXOPLASMOSIS 1
SS PNEUMONIA STREPTOCOCCAL DIARRHOEA 1
SS PNEUMONIA STREPTOCOCCAL DRUG RESISTANCE 1
SS PNEUMONIA STREPTOCOCCAL EAR INFECTION 1
SS PNEUMONIA STREPTOCOCCAL EPILEPSY 1
SS PNEUMONIA STREPTOCOCCAL GASTROINTESTINAL DISORDER 1
SS PNEUMONIA STREPTOCOCCAL HEPATOTOXICITY 1
SS PNEUMONIA STREPTOCOCCAL IMMUNE RECONSTITUTION SYNDROME 1
SS PNEUMONIA STREPTOCOCCAL MENINGITIS 1
SS PNEUMONIA STREPTOCOCCAL MONOPLEGIA 1
SS PNEUMONIA STREPTOCOCCAL NAUSEA 1
SS PNEUMONIA STREPTOCOCCAL OESOPHAGEAL CANDIDIASIS 1
SS PNEUMONIA STREPTOCOCCAL PNEUMONIA STREPTOCOCCAL 1
SS PNEUMONIA STREPTOCOCCAL POLYNEUROPATHY 1
SS PNEUMONIA STREPTOCOCCAL QUADRIPARESIS 1
SS PNEUMONIA STREPTOCOCCAL SEPSIS 1
SS PNEUMONIA STREPTOCOCCAL TREATMENT FAILURE 1
SS PNEUMONIA STREPTOCOCCAL TREATMENT NONCOMPLIANCE 1
SS PNEUMONIA STREPTOCOCCAL VIITH NERVE PARALYSIS 1
SS PNEUMONIA STREPTOCOCCAL VIRAL LOAD INCREASED 1
SS PNEUMONIA STREPTOCOCCAL VOMITING 1
SS PRODUCT USED FOR UNKNOWN INDICATION COUGH 1
SS PRODUCT USED FOR UNKNOWN INDICATION DYSPNOEA 1
SS PRODUCT USED FOR UNKNOWN INDICATION FOETAL EXPOSURE DURING PREGNANCY 1
SS PRODUCT USED FOR UNKNOWN INDICATION HEPATOMEGALY 1
SS PRODUCT USED FOR UNKNOWN INDICATION LACTIC ACIDOSIS 1
SS PRODUCT USED FOR UNKNOWN INDICATION PYREXIA 1
SS PRODUCT USED FOR UNKNOWN INDICATION RENAL FAILURE ACUTE 1
SS PRODUCTIVE COUGH SUICIDAL IDEATION 6
SS PRODUCTIVE COUGH SUICIDE ATTEMPT 9
SS PROPHYLAXIS DEVELOPMENTAL DELAY 1
SS PROPHYLAXIS FOETAL EXPOSURE DURING PREGNANCY 1
SS PROPHYLAXIS HEPATOSPLENOMEGALY 1
SS PROPHYLAXIS LACTIC ACIDOSIS 1
SS PROPHYLAXIS LYMPHADENITIS 1
SS PROPHYLAXIS LYMPHADENOPATHY 1
SS PROPHYLAXIS MENINGITIS CRYPTOCOCCAL 2
SS PROPHYLAXIS MUSCLE SPASTICITY 1
SS PROPHYLAXIS AGAINST HIV INFECTION DIABETES MELLITUS 2
SS ROUTINE HEALTH MAINTENANCE SUICIDAL IDEATION 2
SS ROUTINE HEALTH MAINTENANCE SUICIDE ATTEMPT 3
SS SUPPLEMENTATION THERAPY FOETAL EXPOSURE DURING PREGNANCY 1
SS SUPPLEMENTATION THERAPY PREMATURE BABY 1
SS SUPPLEMENTATION THERAPY VENTRICULAR SEPTAL DEFECT 1
SS THYROID CYST BLOOD THYROID STIMULATING HORMONE INCREASED 1
SS THYROID CYST DRUG INTERACTION 1
C ASYMPTOMATIC HIV INFECTION AGITATION 3
C ASYMPTOMATIC HIV INFECTION CONFUSIONAL STATE 3
C ASYMPTOMATIC HIV INFECTION MALAISE 3
C BASEDOW'S DISEASE DRUG INTERACTION 1
C BLOOD TRIGLYCERIDES INCREASED ABNORMAL SENSATION IN EYE 1
C BLOOD TRIGLYCERIDES INCREASED EYELID OEDEMA 1
C BLOOD TRIGLYCERIDES INCREASED LOCAL SWELLING 1
C BLOOD TRIGLYCERIDES INCREASED SWELLING FACE 1
C HIV INFECTION ANGIOEDEMA 3
C HIV INFECTION CLOSTRIDIUM DIFFICILE COLITIS 2
C HIV INFECTION DRUG INTERACTION 6
C HIV INFECTION DYSPHAGIA 3
C HIV INFECTION DYSPNOEA 3
C HIV INFECTION ENCEPHALOPATHY 2
C HIV INFECTION LUNG DISORDER 2
C HIV INFECTION MATERNAL DRUGS AFFECTING FOETUS 3
C HIV INFECTION RENAL FAILURE ACUTE 2
C HIV INFECTION RESPIRATORY DISTRESS 12
C HIV INFECTION SHOCK 2
C HIV INFECTION SUPERINFECTION 2
C HIV INFECTION VENTRICULAR SEPTAL DEFECT 9
C PRODUCT USED FOR UNKNOWN INDICATION ANGIOEDEMA 6
C PRODUCT USED FOR UNKNOWN INDICATION DYSPHAGIA 6
C PRODUCT USED FOR UNKNOWN INDICATION DYSPNOEA 6
C THYROID CYST DRUG INTERACTION 1
C URINARY TRACT INFECTION GRAND MAL CONVULSION 1
I DYSMENORRHOEA ANAEMIA 4
I DYSMENORRHOEA MENORRHAGIA 4
I HIV INFECTION ANAEMIA 2
I HIV INFECTION MENORRHAGIA 2
I MENORRHAGIA ANAEMIA 4
I MENORRHAGIA MENORRHAGIA 4
Ads by Google